Castleark Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-130,885
Closed -$31.8M 346
2021
Q3
$31.8M Sell
130,885
-107,560
-45% -$26.3M 1.21% 23
2021
Q2
$49.3M Sell
238,445
-68,010
-22% -$13.9M 1.66% 13
2021
Q1
$57.7M Buy
306,455
+22,330
+8% +$3.94M 2.08% 7
2020
Q4
$46.7M Sell
284,125
-7,305
-3% -$1.07M 1.75% 11
2020
Q3
$36.3M Buy
291,430
+186,660
+178% +$23.1M 1.42% 13
2020
Q2
$10.2M Buy
104,770
+99,060
+1,735% +$10.3M 0.44% 49
2020
Q1
$513K Buy
+5,710
New +$739K 0.03% 225

Other funds holding HCA

Castleark Management's HCA Position: Q4 2021 in Review

Castleark Management sold out of HCA Healthcare (HCA) in Q4 2021, closing a stake of 130,885 shares — an estimated $31.8M sold.

Castleark Management first reported a position in HCA in Q1 2020 and held it in 7 quarters. The position peaked at $57.7M in Q1 2021. 948 funds tracked by Wall St. Rank hold HCA as of Q4 2021.

  • Castleark Management reported no remaining HCA Healthcare position as of Q4 2021 after selling out during the quarter.
  • Castleark Management sold 130,885 HCA Healthcare shares in Q4 2021, an estimated $31.8M.
  • Castleark Management first reported a position in HCA Healthcare in Q1 2020 and held it in 7 quarters.
  • Castleark Management's HCA Healthcare position peaked at $57.7M in Q1 2021.
  • 948 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2021.

Based on Castleark Management's 13F filing for Q4 2021, filed 16 Feb 2022.